Published in J Rheumatol on July 01, 1993
Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis (2001) 2.21
The place of methotrexate perioperatively in elective orthopedic surgeries in patients with rheumatoid arthritis. Clin Rheumatol (2008) 1.03
Perioperative management of medications used in the treatment of rheumatoid arthritis. HSS J (2006) 0.96
Perioperative management of immunosuppression in rheumatic diseases--what to do? Rheumatol Int (2009) 0.95
Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol (2011) 0.90
[Recommendations of the German Society for Rheumatology on the perioperative approach under therapy with DMARDs and biologicals in inflammatory rheumatic diseases]. Z Rheumatol (2014) 0.83
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
Inflammatory bowel disease: perioperative pharmacological considerations. Mayo Clin Proc (2011) 0.82
Perioperative management of the patient with rheumatoid arthritis. World J Orthop (2014) 0.80
Prosthetic joint infection in patients with rheumatoid arthritis: an outcome analysis compared with controls. PLoS One (2013) 0.80
[Talonavicular arthrodesis for the rheumatoid foot]. Z Rheumatol (2006) 0.78
[Endoprostheses of the hip joint]. Z Rheumatol (2011) 0.77
Perioperative use of anti-rheumatic agents does not increase early postoperative infection risks: a Veteran Affairs' administrative database study. Rheumatol Int (2014) 0.75
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis (2003) 3.33
Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol (2014) 2.84
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Focal myositis: a localized form of polymyositis? J Rheumatol (1993) 2.05
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis Rheum (2006) 1.96
Endocarditis associated with ANCA. Clin Exp Rheumatol (1994) 1.85
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum (1993) 1.63
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
Inflammatory joint disease after immunizations. A report of two cases. Rev Rhum Engl Ed (1997) 1.61
Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis. Arthritis Rheum (2002) 1.48
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47
Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol (1998) 1.45
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum (1997) 1.44
Sjögren's syndrome comes of age. Semin Arthritis Rheum (1999) 1.43
Ultrasound screening during pregnancy: psychological strain experienced by the investigating staff. Ultrasound Obstet Gynecol (1993) 1.41
Sun exposure and risk of melanoma. Arch Dis Child (2005) 1.40
Measurements of ultracold-neutron lifetimes in solid deuterium. Phys Rev Lett (2002) 1.38
Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Ann Rheum Dis (2003) 1.32
Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum (1992) 1.31
Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol (1998) 1.29
Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis (2004) 1.29
Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol (1999) 1.27
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. Br J Cancer (2008) 1.27
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol (1999) 1.25
Acute osteoporotic vertebral collapse: open study on percutaneous injection of acrylic surgical cement in 20 patients. AJR Am J Roentgenol (1999) 1.23
Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun (2006) 1.22
The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 1.21
Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis (2004) 1.18
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry. Ann Rheum Dis (2012) 1.16
Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis (2006) 1.16
Prosthetic joint infection due to Veillonella dispar. Eur J Clin Microbiol Infect Dis (2001) 1.15
Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci (2007) 1.14
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis (2007) 1.10
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis (2012) 1.09
Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis (1997) 1.09
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis. Ann Rheum Dis (2000) 1.08
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. Ann Rheum Dis (2009) 1.08
Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis. Am J Hum Genet (1993) 1.07
Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis. Clin Exp Immunol (2008) 1.07
Refractory auto-inflammatory syndrome associated with digenic transmission of low-penetrance tumour necrosis factor receptor-associated periodic syndrome and cryopyrin-associated periodic syndrome mutations. Ann Rheum Dis (2006) 1.07
Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis (2007) 1.07
Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria. J Rheumatol (1988) 1.06
Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.06
A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis (2006) 1.04
Objective and subjective sleep disturbances in patients with rheumatoid arthritis. A reappraisal. Arthritis Rheum (1994) 1.04
Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus. Ann Rheum Dis (2008) 1.03
Seven Achilles tendinitis including 3 complicated by rupture during fluoroquinolone therapy. J Rheumatol (1992) 1.03
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial. Arthritis Rheum (2012) 1.03
Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) (1996) 1.02
Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med (2007) 1.02
Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Ann Rheum Dis (2005) 1.01
Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis. Bone (2008) 1.01
Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases. Br J Dermatol (2004) 1.01
Sensitivity of magnetic resonance imaging of the wrist in very early rheumatoid arthritis. Clin Exp Rheumatol (1993) 1.01
Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis (2011) 1.01
Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis. Br J Rheumatol (1996) 1.01
Plagiocephaly: morphometry of skull base asymmetry. Surg Radiol Anat (2003) 0.99
How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol (2005) 0.99
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis (2007) 0.98
Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients. Arthritis Rheum (1994) 0.97
Chordin is underexpressed in ovarian tumors and reduces tumor cell motility. FASEB J (2006) 0.97
Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol (1991) 0.97
Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis (2009) 0.97
Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis (2011) 0.96
Health education intervention strategies: recommendations for future research. Health Educ Q (1995) 0.96
T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sites. Arthritis Rheum (1990) 0.94
Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum (1996) 0.94
Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. Tissue Antigens (2006) 0.94
Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome. Eur J Med (1992) 0.94
Characteristics and survival of 26 patients with paraneoplastic arthritis. Ann Rheum Dis (2007) 0.94
Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol (2001) 0.93
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis (2011) 0.93
Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology (1998) 0.93
Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis (2009) 0.93
Bone mineral density of 704 amateur sportsmen involved in different physical activities. Osteoporos Int (2001) 0.93
Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients. J Rheumatol (1997) 0.92
[Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case]. Rev Rhum Mal Osteoartic (1991) 0.91
Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood. Scand J Immunol (1984) 0.91
Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints. Hum Gene Ther (2005) 0.91
PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints. Eur J Pharm Biopharm (2012) 0.91
Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis. J Rheumatol (1995) 0.91
Stem subsidence after total hip revision: 183 cases at 5.9 years follow-up. Orthop Traumatol Surg Res (2011) 0.90
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis (2005) 0.90
Factors determining a DMARD initiation in early inflammatory arthritis patients. The ESPOIR cohort study. Clin Exp Rheumatol (2009) 0.89